20
Participants
Start Date
December 26, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Lovenox 40mg
Enoxaparin is a blood thinner. It is approved for use in the prevention of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness; inpatient treatment of acute DVT with or without pulmonary embolism; outpatient treatment of acute DVT without pulmonary embolism; Prevention of ischemic complications of unstable angina and non-Q-wave myocardial infarction; treatment of acute ST-segment elevation myocardial infarction(STEMI) managed medically or with subsequent percutaneous coronary intervention. The use of Lovenox has been shown to be safe, and it has also been used widely off-label in pregnancy.
RECRUITING
NorthShore University HealthSystem, Evanston
Lead Sponsor
Endeavor Health
OTHER